One prior systematic review on EPO for TBI by Liu et al. [15] suggests that EPO reduces overall mortality and shortens hospitalization time without increasing the risk of DVT, but does not improve favorable neurological outcomes. The gene discussed is EPO; the disease is deep vein thrombosis.